Screener
Fulgent Genetics, Inc. FLGT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 112,215 | 106,810 |
| Commitments and Contingencies (Note 8) | ||
| Stockholders’ equity | ||
| Common stock, $0.0001 par value per share, 50,000 shares authorized, 34,870 shares issued and 28,851 shares outstanding as of March 31, 2026, and 34,501 shares issued and 31,081 shares outstanding as of December 31, 2025 | 4 | 3 |
| Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding as of March 31, 2026, and December 31, 2025 | — | — |
| Additional paid-in capital | 540,141 | 574,520 |
| Accumulated other comprehensive income | 4,536 | 7,512 |
| Retained earnings | 505,128 | 529,954 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s common stock?
- Fulgent Genetics, Inc. (FLGT) reported common stock of $4K in Q1 2026.
- How has Fulgent Genetics, Inc.'s common stock changed year-over-year?
- Fulgent Genetics, Inc.'s common stock increased by 33.3% year-over-year, from $3K to $4K.
- What is the long-term trend for Fulgent Genetics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from $3K to $3K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Fulgent Genetics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude